'Linkage' pharmaceutical evergreening in Canada and Australia
'Evergreening' is not a formal concept of patent law. It is best understood as a social idea used to refer to the myriad ways in which pharmaceutical patent owners utilise the law and related regulatory processes to extend their high rent-earning intellectual monopoly privileges, particularly over highly profitable (either in total sales volume or price per unit) 'blockbuster' drugs. Thus, while the courts are an instrument frequently used by pharmaceutical brand name manufacturers to prolong...[Show more]
|Collections||ANU Research Publications|
|Source:||Australia and New Zealand Health Policy|
|Faunce_LinkagePharmaceut.pdf||289.91 kB||Adobe PDF|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.